AI Science Tracker

Xiangya Hospital, Central South University

1 discovery from 2020

Discoveries

AI augmentation lifts radiologists in telling COVID-19 from other pneumonia

A CT model trained on 1,186 patients (521 COVID-19, 665 other pneumonia) reached 95% sensitivity and 96% specificity internally, and AUC 0.90 on an independent test set. Radiologist accuracy rose from 85% to 90% with AI assistance. The study is retrospective and the independent-test performance is lower than the internal result.

Technology: Deep-learning CT classifier used as an assistant for radiologists

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: A CT model was tested on an internal split and on an independent test set from separate hospitals, and six radiologists read cases unassisted and then with the model's probabilities.
  • Still unknown: The abstract states no limitations section; performance on independent data was lower (87% vs 96% accuracy) and the sensitivity confidence interval is wide.
  • AI role: The AI classified COVID-19 versus other pneumonia on CT slices and its probabilities were shown to radiologists as decision support.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1148/radiol.2020201491&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 385 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.